(Q53725459)

18 May 2018

title

Treatment of children with homozygous familial hypercholesterolemia: safety and efficacy of low-density lipoprotein apheresis (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1593349

homozygous familial hypercholesterolemia

12 October 2022

main subject

hypercholesterolemia

0 references

0 references

1 reference

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1593349

12 October 2022

1 reference

5

Bilheimer DW

1 reference

18 May 2018

R. Uauy

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1593349

12 October 2022

R. J. Zwiener

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1593349

12 October 2022

M. J. Phillips

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1593349

12 October 2022

M. L. Petruska

series ordinal

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1593349

12 October 2022

language of work or name

English

0 references

publication date

1 June 1992

1 reference

18 May 2018

The Journal of Pediatrics

published in

1 reference

18 May 2018

volume

120

1 reference

18 May 2018

issue

6

1 reference

18 May 2018

page(s)

892-898

1 reference

18 May 2018

Lovastatin therapy in receptor-negative homozygous familial hypercholesterolemia: Lack of effect on low-density lipoprotein concentrations or turnover

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2805%2981956-0

Ileal bypass in the treatment of hyperlipoproteinaemia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2805%2981956-0

Failure of complete bile diversion and oral bile acid therapy in the treatment of homozygous familial hypercholesterolemia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2805%2981956-0

Heart-liver transplantation in a patient with familial hypercholesterolaemia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2805%2981956-0

Liver transplantation to provide low-density-lipoprotein receptors and lower plasma cholesterol in a child with homozygous familial hypercholesterolemia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2805%2981956-0

Three different schedules of low-density lipoprotein apheresis compared with plasmapheresis in patients with homozygous familial hypercholesterolemia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2805%2981956-0

Changes of atherosclerosis of the carotid arteries due to severe familial hypercholesterolemia following long-term plasmapheresis, assessed by duplex scan

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2805%2981956-0

Selective removal of low density lipoprotein by plasmapheresis in familial hypercholesterolemia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2805%2981956-0

LDL-apheresis; potential procedure for prevention and regression of atheromatous vascular lesion

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2805%2981956-0

Specific sorbent of apolipoprotein B-containing lipoproteins for plasmapheresis. Characterization and experimental use in hypercholesterolemic rabbits

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2805%2981956-0

A receptor-mediated pathway for cholesterol homeostasis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2805%2981956-0

Low-density lipoprotein plasmaphaeresis with and without lovastatin in the treatment of the homozygous form of familial hypercholesterolaemia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2805%2981956-0

Treatment of familial hypocholesterolemia by means of specific immunoadsorption

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2805%2981956-0

Low density lipoprotein-pheresis: selective immunoadsorption of plasma lipoproteins from patients with premature atherosclerosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2805%2981956-0

Humoral immune response following extracorporeal immunoadsorption therapy of patients with hypercholesterolemia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2805%2981956-0

Apheretic treatment of severe familial hypercholesterolemia: comparison of dextran sulfate cellulose and double membrane filtration methods for low density lipoprotein removal

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2805%2981956-0

Analysis of low density lipoprotein apheresis: post-treatment rebound using mathematical models

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2805%2981956-0

Effect of HELP-LDL-apheresis on serum concentrations of human lipoprotein(a): kinetic analysis of the post-treatment return to baseline levels

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2805%2981956-0

Beneficial effects of colestipol-niacin on coronary atherosclerosis. A 4-year follow-up

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2805%2981956-0

Regression of coronary artery disease as a result of intensive lipid-lowering therapy in men with high levels of apolipoprotein B

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2805%2981956-0

Long-term clinical experience with HELP-LDL-apheresis in combination with HMG-CoA-reductase inhibitors for maximum treatment of coronary heart disease associated with severe hypercholesterolemia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2805%2981956-0

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1016/S0022-3476(05)81956-0

1 reference

18 May 2018

1 reference

18 May 2018